Sinovac Biotech Ltd (NASDAQ:SVA)
| 0.00 Delayed Data As of Dec 30 |  0.00 / 0.00%Today’s Change | -- |||52-Week Range -- | -- Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 2 2016 | Quarter 3 2016 | Quarter 4 2016 | Quarter 1 2019 | |||
| Operating Activities | Net Income / Starting Line | -12.6M | 4.4M | 6.8M | 3.6M | |
| Depreciation | 1.4M | 1.2M | 887.1K | 1.0M | ||
| Total Other Cash Flow | 3.3M | 875.2K | -754.7K | 586.0K | ||
| Funds From Operations | -7.7M | 6.0M | 6.3M | 4.6M | ||
| Funds From/For Other Operating Expenses | -1.6M | 5.7M | 4.6M | 13.3M | ||
| Net Cash Flow - Operating Activities | -6.0M | 333.0K | 1.7M | -8.7M | ||
| Investing | Capital Expenditures | -1.1M | -3.5M | -4.6M | -557.0K | |
| Fixed Asset Disposal | 489.58 | -13.3K | 478.75 | 0.00 | ||
| Other Investing - Uses | -5.04 | 136.73 | 115.12 | 0.00 | ||
| Net Cash Flow Investing | -1.1M | -3.5M | -4.2M | -557.0K | ||
| Financing | Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Long Term Borrowings | 9.4M | 11.8M | -34.5M | 0.00 | ||
| Long Term Debt Reduction | -15.2M | -3.2M | 21.0M | 0.00 | ||
| Net Proceeds Stock Sale | 765.4K | -593.5K | 112.0K | 3.0K | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Dividends | -- | -- | -- | -- | -- | |
| Cash Dividends Paid - Total | -- | -- | 0.00 | 0.00 | -- | |
| Other Sources - Financing | 0.00 | 0.00 | 6.7M | 174.0K | ||
| Other Uses - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Net Cash Flow - Financing | -5.0M | 8.0M | 13.3M | -1.1M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -1.2M | 414.6K | -1.3M | 1.3M | |
| Net Change In Cash | -12.1M | 4.8M | 10.8M | -10.4M | ||
